Atlas Trials

A Trial to Assess How Centanafadine Interacts With Stimulants in the Body

Clinical trial NCT07314333 · COMPLETED

Trial details

NCT number
NCT07314333
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ADHD
Start date
2026-02-05
Primary completion
2026-03-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.